|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/4985 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 403/04 | (2006.01) |
| (11) | Number of the document | 3374359 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16791420.9 |
| Date of filing the European patent application | 2016-11-08 | |
| (97) | Date of publication of the European application | 2018-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation | 2020-03-25 |
| (86) | Number | PCT/EP2016/076932 |
| Date | 2016-11-08 |
| (87) | Number | WO 2017/080979 |
| Date | 2017-05-18 |
| (30) | Number | Date | Country code |
| 201562252726 P | 2015-11-09 | US | |
| 201662401351 P | 2016-09-29 | US |
| (72) |
WARD, Richard, Andrew, GB
JONES, Clifford, David, GB
SWALLOW, Steven, GB
GRAHAM, Mark, Andrew, GB
DOBSON, Andrew, Hornby, GB
MCCABE, James, Francis, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Dihidroimidazopirazinono deriniai, tinkami panaudoti vėžio gydymui |
| DIHYDROIMIDAZOPYRAZINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2022-11-04 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-11-08 |